Alzheimer's disease (WP5124)

Homo sapiens

Authors

Kristina Hanspers and Eric Weitz

Activity

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

• A Novel Based-Network Strategy to Identify Phytochemicals from Radix Salviae Miltiorrhizae (Danshen) for Treating Alzheimer’s Disease (2022).

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Rare Diseases

Annotations

Pathway Ontology

Alzheimer's disease pathway disease pathway

Disease Ontology

Alzheimer's disease

References

1. Possible causes of Alzheimer’s disease: amyloid fragments, free radicals, and calcium homeostasis. Hölscher C. Neurobiol Dis. 1998 Sep;5(3):129–41. PubMed Europe PMC Scholia
2. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Ivins KJ, Thornton PL, Rohn TT, Cotman CW. Neurobiol Dis. 1999 Oct;6(5):440–9. PubMed Europe PMC Scholia
3. Neurotoxicity induces cleavage of p35 to p25 by calpain. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Nature. 2000 May 18;405(6784):360–4. PubMed Europe PMC Scholia
4. Alzheimer’s disease and Abeta toxicity: from top to bottom. Small DH, Mok SS, Bornstein JC. Nat Rev Neurosci. 2001 Aug;2(8):595–8. PubMed Europe PMC Scholia
5. Alzheimer’s disease pathogenesis and therapeutic interventions. Parihar MS, Hemnani T. J Clin Neurosci. 2004 Jun;11(5):456–67. PubMed Europe PMC Scholia
6. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? Dickson DW. J Clin Invest. 2004 Jul;114(1):23–7. PubMed Europe PMC Scholia
7. Pathways towards and away from Alzheimer’s disease. Mattson MP. Nature. 2004 Aug 5;430(7000):631–9. PubMed Europe PMC Scholia
8. Induction of neuronal death by ER stress in Alzheimer’s disease. Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M. J Chem Neuroanat. 2004 Sep;28(1–2):67–78. PubMed Europe PMC Scholia
9. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer’s disease. Takuma K, Yan SS, Stern DM, Yamada K. J Pharmacol Sci. 2005 Mar;97(3):312–6. PubMed Europe PMC Scholia
10. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. Gandy S. J Clin Invest. 2005 May;115(5):1121–9. PubMed Europe PMC Scholia
11. Tau phosphorylation and aggregation in Alzheimer’s disease pathology. Avila J. FEBS Lett. 2006 May 22;580(12):2922–7. PubMed Europe PMC Scholia
12. Mitochondrial dysfunction in sporadic and genetic Alzheimer’s disease. Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Müller WE. Exp Gerontol. 2006 Jul;41(7):668–73. PubMed Europe PMC Scholia
13. Distinct destructive signal pathways of neuronal death in Alzheimer’s disease. Shen Y, He P, Zhong Z, McAllister C, Lindholm K. Trends Mol Med. 2006 Dec;12(12):574–9. PubMed Europe PMC Scholia
14. Presenilin-mediated signal transduction. Cowburn RF, Popescu BO, Ankarcrona M, Dehvari N, Cedazo-Minguez A. Physiol Behav. 2007 Sep 10;92(1–2):93–7. PubMed Europe PMC Scholia
15. Calcium dysregulation in Alzheimer’s disease. Bojarski L, Herms J, Kuznicki J. Neurochem Int. 2008;52(4–5):621–33. PubMed Europe PMC Scholia
16. Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease. Bezprozvanny I, Mattson MP. Trends Neurosci. 2008 Sep;31(9):454–63. PubMed Europe PMC Scholia
17. Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Reese LC, Zhang W, Dineley KT, Kayed R, Taglialatela G. Aging Cell. 2008 Dec;7(6):824–35. PubMed Europe PMC Scholia
18. RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage. Piras S, Furfaro AL, Domenicotti C, Traverso N, Marinari UM, Pronzato MA, et al. Oxid Med Cell Longev. 2016;2016:9348651. PubMed Europe PMC Scholia
19. Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma. Vallée A, Lecarpentier Y. Front Neurosci. 2016 Oct 19;10:459. PubMed Europe PMC Scholia
20. Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses. Wasser CR, Herz J. J Biol Chem. 2017 Jan 27;292(4):1330–8. PubMed Europe PMC Scholia
21. ApoE, ApoE Receptors, and the Synapse in Alzheimer’s Disease. Lane-Donovan C, Herz J. Trends Endocrinol Metab. 2017 Apr;28(4):273–84. PubMed Europe PMC Scholia
22. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer’s disease. Vargas LM, Cerpa W, Muñoz FJ, Zanlungo S, Alvarez AR. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1148–59. PubMed Europe PMC Scholia
23. Dysregulation of Intracellular Calcium Signaling in Alzheimer’s Disease. Popugaeva E, Pchitskaya E, Bezprozvanny I. Antioxid Redox Signal. 2018 Oct 20;29(12):1176–88. PubMed Europe PMC Scholia
24. Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1. Strickland MR, Holtzman DM. J Clin Invest. 2019 Mar 1;129(3):969–71. PubMed Europe PMC Scholia
25. Wnt Signaling Deregulation in the Aging and Alzheimer’s Brain. Palomer E, Buechler J, Salinas PC. Front Cell Neurosci. 2019 May 22;13:227. PubMed Europe PMC Scholia
26. Role of GPCR signaling and calcium dysregulation in Alzheimer’s disease. Sushma, Mondal AC. Mol Cell Neurosci. 2019 Dec;101:103414. PubMed Europe PMC Scholia